Email updates

Keep up to date with the latest news and content from Infectious Agents and Cancer and BioMed Central.

Open Access Highly Accessed Research article

Consistent condom use increases spontaneous regression in high-risk non-HPV16 but not in HPV16 CIN2-3 lesions, a prospective population-based cohort study

Ane Cecilie Munk1, Irene Tveiterås Øvestad2, Einar Gudlaugsson2, Kjell Løvslett1, Bent Fiane1, Bianca van Diermen-Hidle2, Arnold-Jan Kruse3, Ivar Skaland2, Emiel AM Janssen2 and Jan PA Baak2*

Author Affiliations

1 Department of Obstetrics and Gynecology, Stavanger University Hospital, Stavanger, Norway

2 Department of Pathology, Stavanger University Hospital, Box 8100, 4068, Stavanger, Norway

3 Department of Gynecology, Academic Hospital Maastricht, Maastricht, The Netherlands

For all author emails, please log on.

Infectious Agents and Cancer 2012, 7:30  doi:10.1186/1750-9378-7-30

Published: 5 November 2012

Abstract

Background

The major cause of cervical intraepithelial neoplasia (CIN) is persistent infection with human papillomavirus (HPV). Most CIN grade 2 and 3 lesions are treated with cone excision, although a substantial proportion (6-50%) of CIN2-3 lesions will regresses spontaneously. Predictors for regression of CIN2-3 are desirable in order to reduce this overtreatment.

Methods

In this prospective cohort study, 145 consecutive women with first-time onset CIN2-3 in colposcopy-directed biopsies and standardized biopsy-cone excision interval were included. The genotype of the high-risk human papillomaviruses (=hrHPV) and clinical factors including sexual behaviour, parity, contraception and smoking were assessed. Patients were divided into two groups according to lesions containing HPV16 (hrHPV16+) and high-risk non-HPV16 (hrHPV16-) genotypes.

Results

Women whose partners consistently used condoms showed a significantly higher regression rate than women using other types of contraception (53% versus 13%, p<0.0001). However, this effect was only seen in hrHPV16- patients (73% regression rate versus 13%, p<0.0001). HrHPV16+ patients had a significantly higher number of sexual partners and more current smokers compared to hrHPV16- patients. The regression rate was not significantly different in CIN2-3 lesions containing HPV16 (hrHPV16+) versus hrHPV16- genotypes.

Conclusions

Heterogeneity among hrHPV genotypes excists. HPV-genotype analyses can identify women who significantly increase their chance of regression by consistent condom use.

Keywords:
CIN2-3; High-risk HPV; HPV16; Regression; Condom use; Clinical factors